$2.13 -0.10 (-4.48%)
2/10/2012 4:00 PM

BioMimetic Therapeutics, Inc. (NASDAQ:BMTI)

CAPS Rating: 3 out of 5

The Company develops and commercializes bio-active drug-device combination products for the healing of musculoskeletal injuries and diseases, including periodontal, orthopedic, spine and sports injury applications.

Featured Broker Partners


Advertisement